MAFM
TMO icon

Mid Atlantic Financial Management’s Thermo Fisher Scientific TMO Stock Holding History

Mid Atlantic Financial Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.6M Sell
2,799
-51
-2% -$28K 0.11% 167
2021
Q2 		$1.44M Buy
2,850
+30
+1% +$14.2K 0.1% 175
2021
Q1 		$1.29M Sell
2,820
-33
-1% -$15.8K 0.09% 181
2020
Q4 		$1.33M Buy
2,853
+203
+8% +$95.2K 0.1% 175
2020
Q3 		$1.28M Buy
2,650
+106
+4% +$43.8K 0.11% 163
2020
Q2 		$922K Buy
2,544
+286
+13% +$95.9K 0.09% 203
2020
Q1 		$640K Buy
2,258
+639
+39% +$201K 0.07% 251
2019
Q4 		$526K Buy
1,619
+544
+51% +$165K 0.05% 368
2019
Q3 		$313K Sell
1,075
-43
-4% -$12.3K 0.03% 492
2019
Q2 		$328K Buy
1,118
+56
+5% +$15.4K 0.03% 495
2019
Q1 		$291K Buy
1,062
+76
+8% +$18.9K 0.03% 519
2018
Q4 		$221K Buy
+986
New +$231K 0.03% 558

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mid Atlantic Financial Management's TMO Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q3 2021, selling an estimated $28K and leaving 2,799 shares worth $1.6M. The position accounts for 0.11% of the portfolio, ranked #167.

Mid Atlantic Financial Management first reported a position in TMO in Q4 2018 and has held it in 12 quarters since. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Mid Atlantic Financial Management held 2,799 shares of Thermo Fisher Scientific worth $1.6M as of Q3 2021.
  • Mid Atlantic Financial Management sold 51 Thermo Fisher Scientific shares in Q3 2021, an estimated $28K.
  • Thermo Fisher Scientific made up 0.11% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #167 holding.
  • Mid Atlantic Financial Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 12 quarters since.
  • 2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.